Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Identification of a novel indoline derivative for in vivo fluorescent imaging of blood-brain barrier disruption in animal models.

Nishimura Y, Yata K, Nomoto T, Ogiwara T, Watanabe K, Shintou T, Tsuboyama A, Okano M, Umemoto N, Zhang Z, Kawabata M, Zhang B, Kuroyanagi J, Shimada Y, Miyazaki T, Imamura T, Tomimoto H, Tanaka T.

ACS Chem Neurosci. 2013 Aug 21;4(8):1183-93. doi: 10.1021/cn400010t. Epub 2013 May 23.

2.

In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish.

Watanabe K, Nishimura Y, Nomoto T, Umemoto N, Zhang Z, Zhang B, Kuroyanagi J, Shimada Y, Shintou T, Okano M, Miyazaki T, Imamura T, Tanaka T.

BMC Neurosci. 2012 Aug 16;13:101. doi: 10.1186/1471-2202-13-101.

4.

[Zebrafish as a model animal for the study of blood-brain barrier permeability by biomolecules].

Fu AL, Chen HY, Xu XR, Zhao BQ.

Yao Xue Xue Bao. 2012 Nov;47(11):1447-51. Chinese.

PMID:
23387075
5.

Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice.

Klohs J, Steinbrink J, Bourayou R, Mueller S, Cordell R, Licha K, Schirner M, Dirnagl U, Lindauer U, Wunder A.

J Neurosci Methods. 2009 May 30;180(1):126-32. doi: 10.1016/j.jneumeth.2009.03.002. Epub 2009 Mar 20.

PMID:
19427539
6.
7.

Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis.

Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH.

J Cereb Blood Flow Metab. 2005 Feb;25(2):226-33. Erratum in: J Cereb Blood Flow Metab. 2005 Jul;25(7):937.

PMID:
15678125
8.

In vivo optical imaging of ischemic blood-brain barrier disruption.

Abulrob A, Brunette E, Slinn J, Baumann E, Stanimirovic D.

Methods Mol Biol. 2011;763:423-39. doi: 10.1007/978-1-61779-191-8_29.

PMID:
21874469
9.

In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models.

Leten C, Struys T, Dresselaers T, Himmelreich U.

J Neurooncol. 2014 Sep;119(2):297-306. doi: 10.1007/s11060-014-1514-2. Epub 2014 Jul 3.

PMID:
24990826
10.

Dynamic analysis of the blood-brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging.

Abulrob A, Brunette E, Slinn J, Baumann E, Stanimirovic D.

Mol Imaging. 2008 Nov-Dec;7(6):248-62.

PMID:
19123995
11.

The feasibility of real-time in vivo optical detection of blood-brain barrier disruption with indocyanine green.

Ergin A, Wang M, Zhang JY, Bruce JN, Fine RL, Bigio IJ, Joshi S.

J Neurooncol. 2012 Feb;106(3):551-60. doi: 10.1007/s11060-011-0711-5. Epub 2011 Oct 1.

PMID:
21964696
12.

Functional and developmental analysis of the blood-brain barrier in zebrafish.

Jeong JY, Kwon HB, Ahn JC, Kang D, Kwon SH, Park JA, Kim KW.

Brain Res Bull. 2008 Mar 28;75(5):619-28. doi: 10.1016/j.brainresbull.2007.10.043. Epub 2007 Nov 20.

PMID:
18355638
13.

Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.

Morrey JD, Olsen AL, Siddharthan V, Motter NE, Wang H, Taro BS, Chen D, Ruffner D, Hall JO.

J Gen Virol. 2008 Feb;89(Pt 2):467-73. doi: 10.1099/vir.0.83345-0.

PMID:
18198377
14.

Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.

Dohgu S, Nishioku T, Sumi N, Takata F, Nakagawa S, Naito M, Tsuruo T, Yamauchi A, Shuto H, Kataoka Y.

Cell Mol Neurobiol. 2007 Nov;27(7):889-99. Epub 2007 Oct 13.

PMID:
17934807
15.

Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptide.

On NH, Kiptoo P, Siahaan TJ, Miller DW.

Mol Pharm. 2014 Mar 3;11(3):974-81. doi: 10.1021/mp400624v. Epub 2014 Feb 19.

16.

A new method for determining blood-brain barrier integrity based on intracardiac perfusion of an Evans Blue-Hoechst cocktail.

del Valle J, Camins A, Pallàs M, Vilaplana J, Pelegrí C.

J Neurosci Methods. 2008 Sep 15;174(1):42-9. doi: 10.1016/j.jneumeth.2008.06.025. Epub 2008 Jul 6.

PMID:
18647619
17.

A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB).

Yim YS, Choi JS, Kim GT, Kim CH, Shin TH, Kim DG, Cheon J.

Chem Commun (Camb). 2012 Jan 4;48(1):61-3. doi: 10.1039/c1cc15113d. Epub 2011 Nov 7.

PMID:
22057099
18.

Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat.

Fernández-López D, Faustino J, Daneman R, Zhou L, Lee SY, Derugin N, Wendland MF, Vexler ZS.

J Neurosci. 2012 Jul 11;32(28):9588-600. doi: 10.1523/JNEUROSCI.5977-11.2012.

19.

Blood-brain barrier disruption in the treatment of brain tumors.

Blanchette M, Fortin D.

Methods Mol Biol. 2011;686:447-63. doi: 10.1007/978-1-60761-938-3_23.

PMID:
21082387
20.

Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis.

Guy J, McGorray S, Qi X, Fitzsimmons J, Mancuso A, Rao N.

Ophthalmic Res. 1994;26(5):310-23.

PMID:
7533278

Supplemental Content

Support Center